(Q35027232)

5 August 2017

title

A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer (English)

1 reference

immunofluorescence microscopy

5 August 2017

main subject

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

4

Dario Neri

1 reference

5 August 2017

Gerhard Moser

6

0 references

author name string

Kathrin Schwager

1

1 reference

5 August 2017

Alessandra Villa

2

1 reference

5 August 2017

Christoph Rösli

3

1 reference

5 August 2017

Maria Rösli-Khabas

5

1 reference

5 August 2017

publication date

8 May 2011

1 reference

5 August 2017

1 reference

5 August 2017

volume

3

1 reference

5 August 2017

page(s)

25

1 reference

describes a project that uses

5 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3108933/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108933

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108933

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108933

Antibody-based targeting of the tumor vasculature

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108933

Immunoscintigraphy of patients with head and neck carcinomas, with an anti-angiogenetic antibody fragment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108933

Antibody targeted drugs as cancer therapeutics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108933

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108933

Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-3284-3-25

Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-3284-3-25

The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-3284-3-25

Expression of the Extra Domain B of Fibronectin, a Marker of Angiogenesis, in Head and Neck Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-3284-3-25

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-3284-3-25

Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-3284-3-25

Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1758-3284-3-25

Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21548989

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1758-3284-3-25

1 reference

Dimensions Publication ID

5 August 2017

0 references

0 references

1 reference

5 August 2017

1 reference